Newbury Pharmaceuticals AB Cash Flow Reinvestment Rate
Latest as of February 2026:
0.00x
Newbury Pharmaceuticals AB cash flow reinvestment rate. Newbury Pharmaceuticals AB (NEWBRY) has a Cash Flow Reinvestment Rate of 0.00x as of February 2026, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr2.26 Million. Explore NEWBRY cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr0.00
Capex + Investments
Operating Cash Flow
Skr2.26 Million
SEK
Capital Expenditures
Skr0.00
SEK
Newbury Pharmaceuticals AB Cash Flow Reinvestment Rate by Year (None–None)
Newbury Pharmaceuticals AB cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Newbury Pharmaceuticals AB. For the full cash flow conversion analysis, see Newbury Pharmaceuticals AB (NEWBRY) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow